First Commercially Cloned Dog Delivered To Florida Family BioArts International announced that they have delivered the world's first commercially cloned dog, a 10-week old Labrador named Lancey, to Florida residents Edgar and Nina Otto. "We can't believe this day is finally here," said Nina Otto, "We are so happy to have little Lancey in our family. His predecessor was a very special dog.
Source: www.medicalnewstoday.comLumbar Fusion Has Long-Term Benefits Lumbar fusion is becoming an increasingly common treatment for low-back pain, but its long-term effects are relatively unknown. A doctoral thesis from the Swedish medical university Karolinska Institutet now shows that the long-term effects are superior to those of physiotherapy. Chronic low-back pain is treated increasingly often with lumbar fusion, by which several lower back vertebrae are fused in a way that has little impact on the back's overall mobility.
Source: www.medicalnewstoday.comEzetimibe/Simvastatin (marketed as Vytorin), Ezetimibe (marketed as Zetia), and Simvastatin (marketed as Zocor): Update of Safety Review The
FDA has completed its review of the final clinical study report of ENHANCE and issued an update.
Source: www.fda.govPain Experts Say Greater Focus On High-Tech Non-Animal Research Could Help Thousands Of Patients Science's understanding of human pain remains simplistic, with no safe and effective analgesia for chronic pain despite decades of animal experiments, according to an article published this week by leading pain experts in international peer-reviewed journal Neuroimage [1]. Advanced non-animal technologies such as human brain imaging could offer greater hope for a pain-free future for people living with diseases such as osteoarthritis and fibromyalgia.
Source: www.medicalnewstoday.comAlarming Amounts Of Hipbone Strength Lost By Astronauts On International Space Station Astronauts spending months in space lose significant bone strength, making them increasingly at risk for fractures later in life. UC Irvine and UC San Francisco led a study evaluating 13 astronauts who spent four to six months on the International Space Station and found that, on average, astronauts' hipbone strength decreased 14 percent. Three astronauts experienced losses of 20 percent to 30 percent, rates comparable to those seen in older women with osteoporosis.
Source: www.medicalnewstoday.comWeight Gain In Mice Blocked By Natural Brain Substance, UT Southwestern Researchers Discover Mice with increased levels of a
natural brain chemical don't gain weight when fed a high-fat
diet, researchers at UT Southwestern Medical Center have found. The chemical, orexin, works by increasing the body's sensitivity to the "weight-loss hormone," leptin, the researchers report. Finding a way to boost the orexin system may prove useful as a therapy against obesity, said Dr.
Source: www.medicalnewstoday.comFDA Warns Consumers Against Dietary Supplement Containing Undeclared Drug The U.S. Food and Drug Administration is warning consumers not to take Venom HYPERDRIVE 3.0, a product sold as a dietary supplement and containing sibutramine. Sibutramine, a controlled substance with risks for abuse or addiction, is a potent drug that poses potential safety risks.
Source: www.medicalnewstoday.comUK Breast Screening Information Has Serious Shortcomings The information about breast screening sent to women in the United Kingdom has serious shortcomings and should not be used as a basis for informed consent, warn researchers in a paper published on bmj.com today. Two years ago, Peter Gøtzsche and colleagues at the Nordic Cochrane Centre surveyed breast screening leaflets given to women in six countries, including the UK.
Source: www.medicalnewstoday.comUnified Ophthalmology Gathered To Address Profession's Most Critical Issues The American Academy of Ophthalmology convened the first formal meeting of the Ophthalmic Advocacy Leadership Group (OALG) to collectively address ophthalmology's most pressing advocacy issues. OALG represents the leadership of the ophthalmological subspecialty societies. The meeting took place on Jan. 16 in Baltimore, MD.
Source: www.medicalnewstoday.com
# posted by Network @ 10:09 PM
